Clinical Trial Update: Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sofosbuvir with pegylated interferon and ribavirin in treatment-naive hepatitis C patients has completed and results were posted; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2014-02-19